SCHEMBL3661067

SCHEMBL3661067

NC(=O)C(=O)N1CCN(C(=O)C2CCC2)CC1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
TSHR P16473 1/20 0.63
HPGD P15428 1/20 0.52
HSD11B1 P28845 2/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.46
CHRNB2 P17787 2/20 0.44
CHRNA3 P32297 2/20 0.44
CHRNA4 P43681 2/20 0.44
CHRNB3 Q05901 2/20 0.44
CHRNA6 Q15825 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
GRM5 P41594 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3662921 0.92 ALDH1A1 (0.56) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL30929928 0.80 ALDH1A1 (0.95) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL15076645 0.79 ALDH1A1 (0.68) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL10559542 0.78 ALDH1A1 (1.00) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL1117898 0.78 HPGD (0.81) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL7131881 0.78 ALDH1A1 (1.00) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL3708786 0.78 ALDH1A1 (0.73) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL5808629 0.78 ALDH1A1 (0.59) ALDH1A1TSHRHPGDHSD11B1LMNA
SCHEMBL13387401 0.78
SCHEMBL12714626 0.76 HPGD (0.86) ALDH1A1TSHRHPGDHSD11B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426420-B2 Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists SANOFI (FR) 2013-04-23 US claimed
EP-2238128-B1 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS SANOFI SA (FR) 2012-08-22 EP claimed
EP-2238128-A2 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS Sanofi-Aventis (FR) 2010-10-13 EP claimed
WO-2009080226-A2 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS SANOFIS-AVENTIS (FR) 2009-07-02 WO claimed
US-8426420-B2 Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists SANOFI (FR) 2013-04-23 US disclosed
EP-2238128-B1 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS SANOFI SA (FR) 2012-08-22 EP disclosed
EP-2238128-A2 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS Sanofi-Aventis (FR) 2010-10-13 EP disclosed
WO-2009080226-A2 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS SANOFIS-AVENTIS (FR) 2009-07-02 WO disclosed